公开(公告)号：US20070015758A1

公开(公告)日：2007-01-18

申请号：US11478547

申请日：2006-06-28

申请人： Anima Baruah ,  Dibyendu De ,  Ish Khanna ,  Sivaram Pillarisetti ,  Santanu Maitra ,  Christopher Alexander ,  Jennepalli Sreenu ,  Indu Dager

发明人： Anima Baruah ,  Dibyendu De ,  Ish Khanna ,  Sivaram Pillarisetti ,  Santanu Maitra ,  Christopher Alexander ,  Jennepalli Sreenu ,  Indu Dager

IPC分类号： A61K31/55 ,  A61K31/4709 ,  A61K31/506 ,  A61K31/4706 ,  C07D403/02

CPC分类号： C07D215/14 ,  C07D213/73 ,  C07D213/74 ,  C07D215/38 ,  C07D241/20 ,  C07D401/04 ,  C07D401/12 ,  C07D403/12 ,  C07D413/12 ,  C07D417/12 ,  C07D471/04 ,  C07D498/04

摘要： The present invention provides, among other things, new benzylamine compounds, compositions comprising benzylamine compounds, methods of making benzylamine compounds, and methods of using benzylamine compounds for treating or preventing a variety of conditions or diseases associated with lipoprotein metabolism.

摘要翻译： 本发明尤其提供了新的苄胺化合物，包含苄胺化合物的组合物，制备苄胺化合物的方法，以及使用苄胺化合物治疗或预防与脂蛋白代谢相关的各种病症或疾病的方法。

公开(公告)号：US20060178514A1

公开(公告)日：2006-08-10

申请号：US11320120

申请日：2005-12-28

申请人： Anima Baruah ,  Dibyendu De ,  Ish Khanna ,  Sivaram Pillarisetti ,  Santanu Maitra ,  Christopher Alexander ,  Jennepalli Sreenu

发明人： Anima Baruah ,  Dibyendu De ,  Ish Khanna ,  Sivaram Pillarisetti ,  Santanu Maitra ,  Christopher Alexander ,  Jennepalli Sreenu

IPC分类号： A61K31/4965 ,  A61K31/4745 ,  A61K31/4706 ,  C07D491/02 ,  C07D471/02 ,  C07D215/38

CPC分类号： A61K31/506 ,  A61K31/437 ,  A61K31/438 ,  A61K31/47 ,  A61K31/4709 ,  A61K31/496 ,  C07D213/73 ,  C07D213/74 ,  C07D215/38 ,  C07D221/04 ,  C07D239/78 ,  C07D241/20 ,  C07D401/12 ,  C07D413/12 ,  C07D417/12 ,  C07D471/04 ,  C07D498/04

摘要： The present invention provides, among other things, new benzylamine compounds, compositions comprising benzylamine compounds, methods of making benzylamine compounds, and methods of using benzylamine compounds for treating or preventing a variety of conditions or diseases associated with lipoprotein metabolism.

摘要翻译： 本发明尤其提供了新的苄胺化合物，包含苄胺化合物的组合物，制备苄胺化合物的方法，以及使用苄胺化合物治疗或预防与脂蛋白代谢相关的各种病症或疾病的方法。

公开(公告)号：US20060084644A1

公开(公告)日：2006-04-20

申请号：US11234257

申请日：2005-09-23

申请人： Manojit Pal ,  Christopher Alexander ,  Ish Khanna ,  Javed Iqbal ,  Ram Pillarisetti ,  Santanu Maitra ,  Gayla Roberts ,  Lavanya Sagi ,  Chintakunta Krishna ,  Jennepalli Sreenu

发明人： Manojit Pal ,  Christopher Alexander ,  Ish Khanna ,  Javed Iqbal ,  Ram Pillarisetti ,  Santanu Maitra ,  Gayla Roberts ,  Lavanya Sagi ,  Chintakunta Krishna ,  Jennepalli Sreenu

IPC分类号： A61K31/541 ,  A61K31/5377 ,  A61K31/496 ,  A61K31/4545 ,  A61K31/4439 ,  A61K31/44 ,  C07D417/02 ,  C07D403/02 ,  C07D413/02 ,  C07D401/02

CPC分类号： C07D405/14 ,  C07D239/30 ,  C07D239/40 ,  C07D239/42 ,  C07D239/46 ,  C07D239/47 ,  C07D239/48 ,  C07D239/50 ,  C07D239/54 ,  C07D401/04 ,  C07D403/12 ,  C07D405/12

摘要： The present invention provides new heterocyclic compounds, particularly substituted pyridines, methods and compositions for making and using these heterocyclic compounds, and methods for treating a variety of diseases and disease states, including atherosclerosis, arthritis, restenosis, diabetic nephropathy, or dyslipidemia, or disease states mediated by the low expression of Perlecan.

摘要翻译： 本发明提供新的杂环化合物，特别是取代的吡啶，制备和使用这些杂环化合物的方法和组合物，以及用于治疗各种疾病和疾病状态的方法，包括动脉粥样硬化，关节炎，再狭窄，糖尿病性肾病或血脂异常或疾病 由Perlecan低表达介导的状态。

公开(公告)号：US20060084645A1

公开(公告)日：2006-04-20

申请号：US11234695

申请日：2005-09-23

申请人： Manojit Pal ,  Srinivas Kalleda ,  Srinivas Padakanti ,  Nalivela Swamy ,  Koteswar Yeleswarapu ,  Christopher Alexander ,  Ish Khanna ,  Javed Iqbal ,  Sivaram Pillarisetti ,  Deepak Barange

发明人： Manojit Pal ,  Srinivas Kalleda ,  Srinivas Padakanti ,  Nalivela Swamy ,  Koteswar Yeleswarapu ,  Christopher Alexander ,  Ish Khanna ,  Javed Iqbal ,  Sivaram Pillarisetti ,  Deepak Barange

IPC分类号： A61K31/541 ,  A61K31/5377 ,  A61K31/506 ,  C07D417/02 ,  C07D413/02 ,  C07D403/02

CPC分类号： C07D405/14 ,  C07D239/30 ,  C07D239/40 ,  C07D239/42 ,  C07D239/46 ,  C07D239/47 ,  C07D239/48 ,  C07D239/50 ,  C07D239/54 ,  C07D401/04 ,  C07D403/12 ,  C07D405/12

摘要： The present invention provides new heterocyclic compounds, particularly substituted pyrimidines, methods and compositions for making and using these heterocyclic compounds, and methods for treating a variety of diseases and disease states, including atherosclerosis, arthritis, restenosis, diabetic nephropathy, or dyslipidemia, or disease states mediated by the low expression of Perlecan.

摘要翻译： 本发明提供新的杂环化合物，特别是取代的嘧啶，用于制备和使用这些杂环化合物的方法和组合物，以及用于治疗各种疾病和疾病状态的方法，包括动脉粥样硬化，关节炎，再狭窄，糖尿病性肾病或血脂异常或疾病 由Perlecan低表达介导的状态。

公开(公告)号：US20050227983A1

公开(公告)日：2005-10-13

申请号：US10808210

申请日：2004-03-24

申请人： Richard Timmer ,  Christopher Alexander ,  Sivaram Pillarisetti ,  Uday Saxena ,  Sesha Alluri ,  Velagala Venkata Krishna Reddy ,  Manojit Pal ,  Jangalgar Reddy ,  Koteswar Yeleswarapu ,  Gaddam Reddy ,  Potlapally Kumar

发明人： Richard Timmer ,  Christopher Alexander ,  Sivaram Pillarisetti ,  Uday Saxena ,  Sesha Alluri ,  Velagala Venkata Krishna Reddy ,  Manojit Pal ,  Jangalgar Reddy ,  Koteswar Yeleswarapu ,  Gaddam Reddy ,  Potlapally Kumar

IPC分类号： A61K31/53 ,  A61P19/02 ,  A61P29/00 ,  A61P35/00 ,  C07D251/46 ,  C07D251/52 ,  C12M1/34 ,  C07D43/02

CPC分类号： C07D251/46

摘要： The present invention relates to triazine compounds and their analogs and derivatives, and methods and compositions comprising these compounds. The compounds and compositions of this invention are useful for, among other things, treating pathophysiological conditions arising from inflammatory responses, inhibiting or blocking glycated protein produced induction of the signaling-associated inflammatory response in endothelial cells, inhibiting smooth muscle proliferation, treating vascular occlusive conditions characterized by smooth muscle proliferation such as restenosis and atherosclerosis, and the like.

摘要翻译： 本发明涉及三嗪化合物及其类似物和衍生物，以及包含这些化合物的方法和组合物。 本发明的化合物和组合物尤其可用于治疗由炎症反应引起的病理生理学病症，抑制或阻断糖基化蛋白产生内皮细胞中信号传导相关炎症反应的诱导，抑制平滑肌增生，治疗血管闭塞症状 其特征在于平滑肌增生如再狭窄和动脉粥样硬化等。

公开(公告)号：US20070004729A1

公开(公告)日：2007-01-04

申请号：US11471099

申请日：2006-06-20

申请人： Richard Timmer ,  Christopher Alexander ,  Sivaram Pillarisetti ,  Uday Saxena ,  Koteswar Yeleswarapu ,  Manojit Pal ,  Jangalgar Reddy ,  Velagala Venkata Rama Reddy ,  Sesha Alluri ,  Potlapally Kumar ,  Gaddam Reddy

发明人： Richard Timmer ,  Christopher Alexander ,  Sivaram Pillarisetti ,  Uday Saxena ,  Koteswar Yeleswarapu ,  Manojit Pal ,  Jangalgar Reddy ,  Velagala Venkata Rama Reddy ,  Sesha Alluri ,  Potlapally Kumar ,  Gaddam Reddy

IPC分类号： A61K31/53 ,  C07D403/02 ,  C07D251/54

CPC分类号： A61K31/53 ,  C04B35/632 ,  C07D251/30 ,  C07D251/44 ,  C07D251/46 ,  C07D251/48 ,  C07D251/50 ,  C07D251/52 ,  C07D251/66 ,  C07D251/70 ,  C07D401/04 ,  C07D401/12 ,  C07D401/14 ,  C07D403/04 ,  C07D403/12 ,  C07D403/14 ,  C07D405/12 ,  C07D405/14 ,  C07D409/12 ,  C07D409/14 ,  C07D413/04 ,  C07D413/14 ,  C07D417/04 ,  C07D417/12 ,  C07D417/14 ,  C07D453/02 ,  C07D487/04 ,  C07F9/6521 ,  C07F9/65583

摘要： The present invention relates to methods and compositions comprising compounds that treat pathophysiological conditions arising from inflammatory responses. In particular, the present invention is directed to compounds that inhibit or block glycated protein produced induction of the signaling-associated inflammatory response in endothelial cells. The present invention relates to compounds that inhibit smooth muscle proliferation. In particular, the present invention is directed to compounds that inhibit smooth muscle cell proliferation by modulating HSPGs such as Perlecan. The present invention further relates to the use of compounds to treat vascular occlusive conditions characterized by smooth muscle proliferation such as restenosis and atherosclerosis.

公开(公告)号：US20050137196A1

公开(公告)日：2005-06-23

申请号：US10951316

申请日：2004-09-27

申请人： Richard Timmer ,  Christopher Alexander ,  Sivaram Pillarisetti ,  Uday Saxena ,  Koteswar Yeleswarapu ,  Manojit Pal ,  Jangalgar Reddy ,  Velagala Venkata Krishna Reddy ,  Bhatlapenumarthy Sesha Sridevi ,  Potlapally Kumar ,  Gaddam Reddy

发明人： Richard Timmer ,  Christopher Alexander ,  Sivaram Pillarisetti ,  Uday Saxena ,  Koteswar Yeleswarapu ,  Manojit Pal ,  Jangalgar Reddy ,  Velagala Venkata Krishna Reddy ,  Bhatlapenumarthy Sesha Sridevi ,  Potlapally Kumar ,  Gaddam Reddy

IPC分类号： A61K31/53 ,  C07D251/44 ,  C07D251/46 ,  C07D251/48 ,  C07D251/50 ,  C07D251/52 ,  C07D251/66 ,  C07D251/70 ,  C07D401/04 ,  C07D401/12 ,  C07D401/14 ,  C07D403/04 ,  C07D403/12 ,  C07D403/14 ,  C07D405/12 ,  C07D405/14 ,  C07D409/12 ,  C07D409/14 ,  C07D413/14 ,  C07D417/04 ,  C07D417/12 ,  C07D417/14 ,  C07D453/02 ,  C07D487/04 ,  C07F9/6521 ,  C07F9/6558 ,  C07D251/18 ,  C07D43/02

CPC分类号： A61K31/53 ,  C04B35/632 ,  C07D251/30 ,  C07D251/44 ,  C07D251/46 ,  C07D251/48 ,  C07D251/50 ,  C07D251/52 ,  C07D251/66 ,  C07D251/70 ,  C07D401/04 ,  C07D401/12 ,  C07D401/14 ,  C07D403/04 ,  C07D403/12 ,  C07D403/14 ,  C07D405/12 ,  C07D405/14 ,  C07D409/12 ,  C07D409/14 ,  C07D413/04 ,  C07D413/14 ,  C07D417/04 ,  C07D417/12 ,  C07D417/14 ,  C07D453/02 ,  C07D487/04 ,  C07F9/6521 ,  C07F9/65583

摘要： The present invention relates to methods and compositions comprising compounds that treat pathophysiological conditions arising from inflammatory responses. In particular, the present invention is directed to compounds that inhibit or block glycated protein produced induction of the signaling-associated inflammatory response in endothelial cells. The present invention relates to compounds that inhibit smooth muscle proliferation. In particular, the present invention is directed to compounds that inhibit smooth muscle cell proliferation by modulating HSPGs such as Perlecan. The present invention further relates to the use of compounds to treat vascular occlusive conditions characterized by smooth muscle proliferation such as restenosis and atherosclerosis.

公开(公告)号：US20070117795A1

公开(公告)日：2007-05-24

申请号：US11511129

申请日：2006-08-28

申请人： Richard Timmer ,  Christopher Alexander ,  Sivaram Pillarisetti ,  Uday Saxena ,  Koteswar Yeleswarapu ,  Manojit Pal ,  Jangalgar Reddy ,  Velagala Venkata Rama Krishna Reddy ,  Sesha Alluri ,  Potlapally Kumar ,  Gaddam Reddy

发明人： Richard Timmer ,  Christopher Alexander ,  Sivaram Pillarisetti ,  Uday Saxena ,  Koteswar Yeleswarapu ,  Manojit Pal ,  Jangalgar Reddy ,  Velagala Venkata Rama Krishna Reddy ,  Sesha Alluri ,  Potlapally Kumar ,  Gaddam Reddy

IPC分类号： A61K31/541 ,  A61K31/5377 ,  A61K31/53 ,  C07D417/02 ,  C07D413/02 ,  C07D403/02

CPC分类号： A61K31/53 ,  C04B35/632 ,  C07D251/30 ,  C07D251/44 ,  C07D251/46 ,  C07D251/48 ,  C07D251/50 ,  C07D251/52 ,  C07D251/54 ,  C07D251/66 ,  C07D251/70 ,  C07D401/04 ,  C07D401/12 ,  C07D401/14 ,  C07D403/04 ,  C07D403/12 ,  C07D403/14 ,  C07D405/12 ,  C07D405/14 ,  C07D409/12 ,  C07D409/14 ,  C07D413/04 ,  C07D413/12 ,  C07D413/14 ,  C07D417/04 ,  C07D417/12 ,  C07D417/14 ,  C07D453/02 ,  C07D471/04 ,  C07D487/04 ,  C07F9/6521 ,  C07F9/65583

摘要： The present invention relates to methods and compositions comprising compounds that treat pathophysiological conditions arising from inflammatory responses. In particular, the present invention is directed to compounds that inhibit or block glycated protein produced induction of the signaling-associated inflammatory response in endothelial cells. The present invention relates to compounds that inhibit smooth muscle proliferation. In particular, the present invention is directed to compounds that inhibit smooth muscle cell proliferation by modulating HSPGs such as Perlecan. The present invention further relates to the use of compounds to treat vascular occlusive conditions characterized by smooth muscle proliferation such as restenosis and atherosclerosis.

公开(公告)号：US20060258641A1

公开(公告)日：2006-11-16

申请号：US11441326

申请日：2006-05-25

申请人： Richard Timmer ,  Christopher Alexander ,  Sivaram Pillarisetti ,  Uday Saxena ,  Koteswar Yeleswarapu ,  Manojit Pal ,  Jangalgar Reddy ,  Velagala Venkata Rama Reddy ,  Sesha Alluri ,  Potlapally Kumar ,  Gaddam Reddy

发明人： Richard Timmer ,  Christopher Alexander ,  Sivaram Pillarisetti ,  Uday Saxena ,  Koteswar Yeleswarapu ,  Manojit Pal ,  Jangalgar Reddy ,  Velagala Venkata Rama Reddy ,  Sesha Alluri ,  Potlapally Kumar ,  Gaddam Reddy

IPC分类号： A61K31/55 ,  A61K31/53 ,  C07D403/02 ,  C07D409/02

CPC分类号： A61K31/53 ,  C07D251/30 ,  C07D251/44 ,  C07D251/46 ,  C07D251/48 ,  C07D251/50 ,  C07D251/52 ,  C07D251/66 ,  C07D251/70 ,  C07D401/04 ,  C07D401/12 ,  C07D401/14 ,  C07D403/04 ,  C07D403/12 ,  C07D403/14 ,  C07D405/12 ,  C07D405/14 ,  C07D409/12 ,  C07D409/14 ,  C07D413/04 ,  C07D413/14 ,  C07D417/04 ,  C07D417/12 ,  C07D417/14 ,  C07D453/02 ,  C07D487/04 ,  C07F9/6521 ,  C07F9/65583

摘要： The present invention relates to methods and compositions comprising compounds that treat pathophysiological conditions arising from inflammatory responses. In particular, the present invention is directed to compounds that inhibit or block glycated protein produced induction of the signaling-associated inflammatory response in endothelial cells. The present invention relates to compounds that inhibit smooth muscle proliferation. In particular, the present invention is directed to compounds that inhibit smooth muscle cell proliferation by modulating HSPGs such as Perlecan. The present invention further relates to the use of compounds to treat vascular occlusive conditions characterized by smooth muscle proliferation such as restenosis and atherosclerosis.

公开(公告)号：US20060172984A1

公开(公告)日：2006-08-03

申请号：US11284757

申请日：2005-11-22

申请人： Richard Timmer ,  Christopher Alexander ,  Sivaram Pillarisetti ,  Uday Saxena ,  Yeleswarapu Rao ,  Manojit Pal ,  Jangalgar Reddy ,  Velagala Venkata Rama Reddy ,  Sesha Alluri ,  Potlapally Kumar ,  Gaddam Reddy

发明人： Richard Timmer ,  Christopher Alexander ,  Sivaram Pillarisetti ,  Uday Saxena ,  Yeleswarapu Rao ,  Manojit Pal ,  Jangalgar Reddy ,  Velagala Venkata Rama Reddy ,  Sesha Alluri ,  Potlapally Kumar ,  Gaddam Reddy

IPC分类号： A61K31/53 ,  C07D403/14

CPC分类号： A61K31/53 ,  C04B35/632 ,  C07D251/30 ,  C07D251/44 ,  C07D251/46 ,  C07D251/48 ,  C07D251/50 ,  C07D251/52 ,  C07D251/66 ,  C07D251/70 ,  C07D401/04 ,  C07D401/12 ,  C07D401/14 ,  C07D403/04 ,  C07D403/12 ,  C07D403/14 ,  C07D405/12 ,  C07D405/14 ,  C07D409/12 ,  C07D409/14 ,  C07D413/04 ,  C07D413/14 ,  C07D417/04 ,  C07D417/12 ,  C07D417/14 ,  C07D453/02 ,  C07D487/04 ,  C07F9/6521 ,  C07F9/65583

摘要： The present invention relates to methods and compositions comprising compounds that treat pathophysiological conditions arising from inflammatory responses. In particular, the present invention is directed to compounds that inhibit or block glycated protein produced induction of the signaling-associated inflammatory response in endothelial cells. The present invention relates to compounds that inhibit smooth muscle proliferation. In particular, the present invention is directed to compounds that inhibit smooth muscle cell proliferation by modulating HSPGs such as Perlecan. The present invention further relates to the use of compounds to treat vascular occlusive conditions characterized by smooth muscle proliferation such as restenosis and atherosclerosis.

摘要翻译： 本发明涉及包含治疗由炎性反应引起的病理生理状况的化合物的方法和组合物。 特别地，本发明涉及抑制或阻断糖基化蛋白质产生内皮细胞中信号传导相关炎症反应诱导的化合物。 本发明涉及抑制平滑肌增殖的化合物。 特别地，本发明涉及通过调节HSPG例如Perlecan抑制平滑肌细胞增殖的化合物。 本发明还涉及化合物用于治疗以平滑肌增生为特征的血管闭塞症状，例如再狭窄和动脉粥样硬化。